01
Commercial Reset
When to call. Growth has plateaued, or the commercial functions have drifted apart.
What's different afterward
A clear ideal healthcare buyer, one shared story, a sequenced plan, and an operating rhythm leadership actually runs.
Healthcare & Life Sciences (HLS) · Senior Commercial Growth Advisory
When activity isn't converting into growth with HLS customers.
Biomavens helps HLS-facing companies — from health tech and health IT to services, consulting, agency, and commercialization firms — turn sales, marketing, delivery, and client activity into a clearer commercial engine.
Turning commercial activity into clearer growth. Helping capability become traction with HLS customers — and the operating discipline to make it stick.
Commercial activity
SalesMarketingDeliveryRelationshipsPositioningClient Signals
→→→
Biomavens
Commercial Clarity
Signals → Priorities → Commercial Action
→→→
Growth engine
PipelineExpansionStrategic AccountsRevenueGrowth
Turning commercial activity into a clearer growth engine.
Where leaders bring us in
When capability exists — but growth stops compounding.
Plenty of activity. Not enough compounding growth.
What companies experience today
Activity↑
Meetings↑
Proposals↑
Conversations↑
Growth↔
Pipelineinconsistent
Positioningunclear
Repeatable system—
How Biomavens works
- 01Signal clarity
- 02Commercial focus
- 03Growth architecture
- 04Connected execution
Strong capability, weak market traction
Platform value isn't landing with the buyer
Seen as a vendor, not a partner
Founder-led growth isn't scaling
Strategic accounts aren't expanding
Client work creates signals no one acts on
The sales motion isn't repeatable
Healthcare buyer complexity is slowing the cycle
The pitch works in the deck, not in the room
How we work
Clarify what matters. Reconnect commercial motion. Build repeatable growth.
A candid read on what's really going on. The decisions that move everything else, named out loud. Then the operating discipline to keep making them.
What an engagement looks like
Questions
→Decisions
→Signals
→Interpretation
→Decision-Ready Format
→Activation
→Outcomes
Clarify what matters
What's really going on — and what actually moves the number.
Reconnect commercial motion
The decisions, handoffs, and priorities that got fragmented.
Build repeatable growth
A commercial system that compounds — not just founder energy.
What we do
A small set of capabilities, applied to the work that actually moves HLS revenue.
From founder-led growth to a scalable commercial engine.
02
Capability-to-Market Strategy
When to call. The platform, service, data, or AI capability is real — but the market path to scale isn't.
What's different afterward
Positioning, a packaged offer, and a sales motion shaped around how healthcare buyers actually decide.
03
Strategic Account Growth
When to call. Key accounts are stuck at delivery and the expansion conversation isn't opening.
What's different afterward
Accounts reframed around executive priorities — with a credible path from vendor to advisor.
04
Consultant-Led Growth
When to call. The services firm delivers strong client work, but BD, consultants, account leaders, and delivery teams aren't aligned around expansion and commercial follow-through.
What's different afterward
A growth model where consultant signals become pipeline — with handoff discipline, account planning, and a playbook the services team can run.
05
Executive Advisory
When to call. A founder or commercial leader needs an outside read on decisions already in motion.
What's different afterward
A second perspective, sharper priorities, and a working cadence between us.
06
Strategic Introductions & Partnerships
When to call. The constraint isn't capability. It's access to the right rooms inside healthcare.
What's different afterward
A targeted map of partners and buyers, and warm introductions where they matter.
Selected Impact
Where the work has moved the number.
Representative outcomes across services firms, healthcare AI vendors, enterprise platforms, and other companies whose growth depends on winning HLS customers.
From Plateau to 3x Growth
Took a healthcare communications firm from a stalled revenue line to 3x multi-year growth — diversifying a concentrated client base into a multi-million-dollar enterprise book and building the commercial engine underneath it.
Commercial Build from Scratch
Stood up the commercial organization for an early-stage healthcare AI company — positioning, sales motion, first enterprise customers, and the operating model that carried it from Series A into commercial scale.
Seven-Figure Revenue Activation
Scaled an enterprise consulting business to seven-figure recurring revenue through tighter customer focus, repositioning, sales infrastructure, and operating discipline.
Pre-Launch Pressure Test
Pressure-tested commercial assumptions, payer realities, and adoption barriers for emerging life sciences organizations — reshaping go-to-market posture before capital was committed.
Who we work with
The organizations we're built for.
HLS-facing companies — health tech, health IT, AI and data vendors, platforms, services firms, agencies, consultancies, and commercialization partners — at the point where strong capability has to turn into repeatable growth with HLS buyers.
Health tech, health IT & enterprise platforms
AI, data, workflow, CRM, and martech platforms selling into HLS buyers and trying to be valued for outcomes, not features.
Services, agencies & consultancies
Medcomms, advertising, advisory, and tech-enabled services firms scaling beyond founder-led and relationship-led growth.
Healthcare AI & digital health vendors
Translating model and product capability into enterprise adoption inside complex healthcare & life sciences buyers.
Market access, engagement & commercialization vendors
Companies whose work touches access, evidence, and field execution — and needs to land higher in the HLS buyer.
Data, analytics & enablement platforms
Health IT and commercialization-support firms turning capability into a repeatable motion with HLS customers.
Founder-led and PE-backed HLS-facing businesses
Inflection points where capability and revenue are real, and the next phase of growth has to be built deliberately.
Why Biomavens
Built where strategy and operating reality meet.
Most advisors live in strategy or in execution. Biomavens was built at the seam — from inside the HLS buyers that decide what gets funded and adopted, and alongside the platforms, services firms, agencies, and vendors trying to land there.
Built where HLS buyers actually decide
Operating depth across payer, provider, pharma, and digital health — built inside the organizations our clients are trying to sell into, so we know what makes the buying conversation move.
Strategy and execution, not one or the other
Commercial work rarely fails on the strategy alone. It fails where people, process, and platforms meet daily decisions.
A repeatable method
A working approach to turning fragmented signals into clear choices — teachable across a leadership team, not locked in one head.
Decisions, not dashboards
Strategy stays connected to execution through an operating cadence — and a clear line from signal to decision to action.
How we engage
Sized to the moment — not to a fixed deliverable.
Engagements are scoped to a decision or an outcome, not a stack of slides. Most start with a short working session to frame the real problem.
Strategic Advisory
Recurring senior judgment at the leadership table.
Commercial Diagnostic
A short, structured read on where commercial reality is breaking down.
Go-to-Market & Market Readiness
Positioning, customer focus, motion, and access — scoped to the launch ahead.
Sales Activation
The story, the playbook, and the cadence that actually moves pipeline.
Decision Environments
Workflows that turn signals into decisions and decisions into action.
Embedded Commercial Support
Fractional commercial leadership through a critical growth window.
From capability to commercial motion
A capability is not a strategy. The market has to understand what it's buying.
A strong platform, service, data asset, or AI capability doesn't sell itself. It sells when buyers can see the problem it solves, the decision it supports, and the outcome it changes.
01
Turn capability into a motion the field can run.
Real platforms, services, and AI assets that aren't yet a clear offer, a buyer story, or a repeatable sales motion. We translate what you have into something the market can actually buy.
The translation
Capability→Buyer Problem→Value Narrative→Packaged Offer→Sales Motion→Growth
02
Move the conversation from features to value.
Technology and services firms often get stuck talking implementation when the buyer wants to talk outcomes. We help reframe the account conversation around the decisions, workflows, and results that actually move the relationship.
The translation
Platform→Buyer Decision→Workflow Impact→Account Growth→Measurable Value
Firms lose strategic ground the moment the conversation becomes about features and delivery instead of decisions and outcomes. Most of what we do lives in that gap.
Built inside healthcare commercialization
A senior operator, not a career consultant.
Biomavens is led by Mike Strassberg — more than three decades inside healthcare & life sciences, working at the intersection of HLS buyers and the companies that sell into them: platforms, services firms, AI and data companies, agencies, and consultancies.
The work has spanned commercial builds, growth resets, account expansion, and executive advisory through repositioning and transformation. Initial conversations are led personally.
More on the founder →Engage Biomavens
If commercialization has to land — not just be announced — let's talk.
Bring the problem you're already losing sleep over. We'll frame it, decide together whether there's a fit, and shape what the work would look like.